Home > Insider Trading > Filing (0001209191-11-029527)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1120362	F Paul Truex	C/O Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward CA 94545	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-05-03	30,000	$0.00	91,122	No	5	G	Direct
Common Stock	Acquisiton	2011-05-03	30,000	$0.00	716,003	No	5	G	Indirect	By trust
Common Stock	Disposition	2011-05-09	9,000	$0.00	707,003	No	5	G	Indirect	By trust
Common Stock	Disposition	2011-05-16	15,000	$7.16	692,003	No	4	S	Indirect	By trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Indirect	By trust
No	5	G	Indirect	By trust
No	4	S	Indirect	By trust

Footnotes

The Reporting Person transferred 30,000 shares to The 2005 Truex Family Trust u/d/t April 20, 2005 on May 3, 2011.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 1, 2011.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $7.10 to $7.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.